Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies

Risultato della ricerca: Article

35 Citazioni (Scopus)

Abstract

Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.
Lingua originaleEnglish
pagine (da-a)2-13
Numero di pagine12
RivistaEurosurveillance
Volume23
Stato di pubblicazionePublished - 2018

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Public Health, Environmental and Occupational Health
  • Virology

Fingerprint Entra nei temi di ricerca di 'Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies'. Insieme formano una fingerprint unica.

  • Cita questo